|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Imatinib Mesylate for Targeting
the Platelet-Derived Growth Factor Beta Receptor in Combination
with Fluorouracil and Leucovorin in Patients with Refractory
Pancreatic, Bile Duct, Colorectal, or Gastric Cancer-A Dose-Escalation
Phase I Trial 2007 May 1;109(9):1897-904. PMID:
17377918 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |